GORACCI, Gianfrancesco
 Distribuzione geografica
Continente #
NA - Nord America 3.601
EU - Europa 2.773
AS - Asia 1.981
SA - Sud America 271
AF - Africa 27
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 3
AN - Antartide 1
Totale 8.662
Nazione #
US - Stati Uniti d'America 3.530
SG - Singapore 909
UA - Ucraina 624
IE - Irlanda 535
SE - Svezia 388
CN - Cina 324
HK - Hong Kong 309
IT - Italia 257
RU - Federazione Russa 248
BR - Brasile 243
DE - Germania 234
FI - Finlandia 175
KR - Corea 152
VN - Vietnam 136
GB - Regno Unito 109
TR - Turchia 46
CA - Canada 41
BE - Belgio 39
FR - Francia 36
PL - Polonia 29
CH - Svizzera 23
IN - India 23
NL - Olanda 17
MX - Messico 16
UZ - Uzbekistan 16
BD - Bangladesh 15
AT - Austria 12
ES - Italia 12
ZA - Sudafrica 11
AR - Argentina 9
IQ - Iraq 9
AE - Emirati Arabi Uniti 7
GR - Grecia 7
CZ - Repubblica Ceca 6
JP - Giappone 6
EC - Ecuador 5
EU - Europa 5
ID - Indonesia 5
LT - Lituania 5
SA - Arabia Saudita 5
CO - Colombia 4
PK - Pakistan 4
VE - Venezuela 4
DZ - Algeria 3
EG - Egitto 3
HN - Honduras 3
IL - Israele 3
JM - Giamaica 3
MA - Marocco 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AL - Albania 2
AZ - Azerbaigian 2
BN - Brunei Darussalam 2
DO - Repubblica Dominicana 2
IM - Isola di Man 2
JO - Giordania 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
RS - Serbia 2
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
CL - Cile 1
DK - Danimarca 1
EE - Estonia 1
IR - Iran 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
LY - Libia 1
ME - Montenegro 1
MT - Malta 1
MU - Mauritius 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
TN - Tunisia 1
Totale 8.662
Città #
Chandler 665
Singapore 554
Dublin 535
Jacksonville 324
Hong Kong 308
Ashburn 239
San Mateo 237
Boardman 171
Ann Arbor 165
Seoul 151
Santa Clara 133
Medford 111
Princeton 108
Munich 98
Wilmington 93
Beijing 77
Moscow 72
Andover 59
Piscataway 52
Dong Ket 45
Des Moines 39
Los Angeles 39
Brussels 38
Izmir 37
Turku 35
New York 34
Perugia 33
Ho Chi Minh City 32
Houston 31
Woodbridge 29
Helsinki 27
Altamura 26
Saint Petersburg 26
São Paulo 26
Rome 23
Auburn Hills 20
Lawrence 19
Dallas 16
Montreal 16
Norwalk 16
Falls Church 15
Hanoi 15
Warsaw 15
Frankfurt am Main 14
Atlanta 13
Brooklyn 13
Denver 13
Shanghai 13
Chennai 12
Milan 12
The Dalles 12
Chicago 11
Belo Horizonte 10
Boston 10
Johannesburg 9
Mexico City 9
Orem 9
Stockholm 9
Toronto 9
Città Di Castello 8
Rio de Janeiro 8
Guangzhou 7
London 7
Ottawa 7
Poplar 7
San Francisco 7
Amsterdam 6
Ankara 6
Betim 6
Secaucus 6
Changsha 5
Columbus 5
Dhaka 5
Espoo 5
Grugliasco 5
Ninh Bình 5
Phoenix 5
Redwood City 5
Seattle 5
Tashkent 5
Tianjin 5
Tokyo 5
Biên Hòa 4
Busto Arsizio 4
Campinas 4
Carney 4
Charlotte 4
Cisterna di Latina 4
Council Bluffs 4
Edinburgh 4
Falkenstein 4
Manchester 4
Southend 4
Xi'an 4
Baghdad 3
Bexley 3
Brasília 3
Bắc Ninh 3
Curitiba 3
Da Nang 3
Totale 5.183
Nome #
L’infiltrazione intradetrusoriale di tossina botulinica A riduce i livelli tissutali vescicali di nerve growth factor in pazienti affetti da iperattività detrusoriale neurogena. 210
Activation of human platelet phospholipase A2 induced by phisiological agonist or fluoroaluminate: effec of inhibitors of protein kinases 166
Activation of phospholipase A2 and B-thromboglobulin release in human platelets: comparative effects of thrombin and fluoroaluminate stimulation. 154
Characterization of nuclear secretory phospholipase A2 (sPLA2) 142
Studio di un'attività fosfolipasica presente nei nuclei di cellule gliali e neuronali di corteccia cerebrale di ratto. 125
Misurazione del PAF (fattore attivante le piastrine) nella saliva umana; standardizzazione del metodo 124
Characterization of a phospholipase A2 present in purified nuclei from rat brain cortex . INTERNATIONAL CONFERENCE ON PHOSPHOLIPASE A2 116
The induction of long-term potentiation (LTP) in the medial vestibular nuclei enhances the activities of enzymes involved in the synthesis of platelet-activating-factor (PAF). 115
PAF-synthesizing enzyme activities increase during long-term potentiation in the rat medial vestibular nuclei 109
Analysis by high performance liquid chromatography of the water-soluble precursors of choline and ethanolamine phosphoglycerides in the rat brain 109
Mitochondrial localization of sPLA2-IIA in neuronal cell 108
RELEASE OF GROUP IIA SECRETORY PHOSPHOLIPASE A2 FROM RAT BRAIN MITOCHONDRIA: DOES IT CORRELATE WITH THAT OF CYTOCHROME c? 108
Phospholipase A2 activity in rat brain nuclei. 107
Release of group IIA secretory phospholipase A2 from rat brain mitochondria: does it correlated with that of cytochrome c? 107
Properties of phospholipase A2 in the nuclear fraction of rat brain cortex 106
Immunolocalization of secretory phospholipases A2 (sPLA2) in neural cells 105
Rat brain release a phospholipase A2 having properties similar those of the typr II secretory enzymes 104
Is isoprostane 8-iso-PGF2a a reliable marker of different velico-sphincter dysfunction? 102
Botulinum A toxin intravesical treatment induces a reduction of nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity. 98
Group II phospholipase A2 (GIIA) is involved in neuritogenesis in NGF-treated PC12 cells. 98
Localisation and properties of Phospholipases A2 in rat brain cortex mithocondria assayed with labelled E.Coli membranes as substrates. 97
EFFECT OF NGF ON PHOSPHOLIPASES A2 LOCALIZATION IN PC12 CELLS 96
Cloricromene inhibits G-Protein mediated activation of phospholipase A2 in human platelets 95
The presence of a secretory phospholipase A2 in the nuclei of neuronal and glial cells of rat brain cortex. 94
Bladder tissue levels of nerve growth factor in patients with benign prostatic hyperplasia and detrusor overactivity treated with tamsulosin. 94
Protein kinase C inhibitors enhance G-protein induced phospholipase A2 activation in intact human platelets 94
Characterization of a Phospholipases A2 present in purified nuclei from brain cortex 94
NGF Induces the Expression of Group IIA Secretory Phospholipase A2 in PC12 Cells: The Newly Synthesized Enzyme Is Addressed to Growing Neurites 94
Fusion of human platelets with cytidine-5-phospate loaded liposomes: effect on arachidonic acid release. 92
Effect of NGF on the Subcellular Localization of Group IIA Secretory Phospholipase A2 (GIIA) in PC12 Cells: Role in Neuritogenesis. 92
Down-regulation of fluoroaluminate-induced release of arachidonic acid by protein kinase C is calcium-dependent and not related to secretory phospholipase A2 91
The release of arachidonic acid (AA ) by human platelets stimulated by fluoroaluminate and low concetration of collagene potentiated by inhibitors of protein kinase C (PKC). 90
Botulinum-A toxin injections into the detrusor muscle reduce nerve growth factor bladder tissue levels in patients affected by neurogenic detrusor overactivity. 90
Brain secretory phospholipase A2: functions and roles in neurodegenerative diseases 90
Bladder tissue levels of NGF in SCI patients with detrusor overactivity before and after botulinum-A toxin injections into the detrusor muscle 89
Platelet activating factor : a potential retrograde messenger in long term potentiation of the rat medial vestibular nuclei. 89
The synthesis of choline and etrhanolamine phosphoglycerides in neuronal and glial cells of rabbit in vitro. 87
Choline plasmalogen biosynthesis by transmethylation in human platelets 87
Immunolocalization of secretory phospholipases A2 (sPLA2) in neural cells 86
BOTULINUM-A TOXIN INJECTIONS INTO THE DETRUSOR MUSCLE REDUCE NERVE GROWTH FACTOR BLADDER TISSUE LEVELS IN P A TIENTS AFFECTED BY NEUROGENIC DETRUSOR OVER- ACTIVITY 86
Role of Platelet activating factor in the long term potentiation of the rat medial vestibular nuclei. 85
Characterization of rat brain phospholipases A2 and their possible role in cellular signaling 85
High pressure liquid chromatography (HPLC) of water-soluble precursors of choline and ethanolamine phosphoglycerides in animal tissues 85
Botulinum A toxin intradetrusorial injections modulate the bladder expression of NGF, TRKA, P75 and TRPV1 in patients with detrusor overactivity. 85
Group B streptococcus (GBS) causes macrophage PLA2s activation and modification of phosphatidyl- serine metabolism during induction of apoptosis 85
Determination of nerve growth factor levels into human bladder wall by modified enzyme-linked immunoabsorbent assay. 84
Lipid metabolism during early ischemia 84
Brain secreted phospholipases A2 (sPLA2) as intra- and extra-cellular mediators 83
Brain mitochondrial phospholipases A2: functions and role in cell death 83
Distribution of secretory phospholipase A2 (PLA2) in neural cells 83
Platelet-activating factor and group I metabotropic glutamate receptors interact for full development and maintenance of long-term potentiation in the rat medial vestibular nuclei. 82
Nerve Growth Factor bladder tissue levels in patients with benign prostatic hyperplasia and detrusor overactivity treated with tamsulosin. 80
Reversible inhibition of hydrogen peroxide elimination by calcium in brain mitochondria 80
CHARACTERIZATION OF NUCLEAR SECRETORY PHOSPHOLIPASE A2 (sPLA2) 80
Subcellular localization of secretory phospholipases A2 (sPLA2) group IIA (GIIA) and group V (GV) in neural cells 80
Brain secretory phospholipases A2: role in neurodegeneration. 79
Effect of protein kinase inhibitors on HFS-induced long term potentiation and activation of PAF-synthesizing enzymes in rat medial vestibular nuclei. 78
Presence of Group V Phospholipase A2 in rat brain cortex nuclei. 78
Enhancement of PAF-synthesizing enzyme activities during long-term potentiation (LTP) in rat brain-stem slices 77
Cholinephosphotransferase activity in human platelet 77
Properties of phospholipase A2 in the nuclear fraction of rat brain cortex. European Society of Neurochemistry and International Society of Neurochemistry (ESN-ISN) 76
The metabolism of labelled ethanolamine in neuronal and glial cells of the rabbit in vivo. 75
Enzymic synthesis of 1-alkyl-2-acyl-sn-glycero-3-phosphorylethanolamine through ethanolaminephosphotransferase activity in the neuronal and glial cells of rabbit in vitro 75
Presence of Group V Phospholipase A2 in rat brain cortex nuclei 75
Is the cytosolic phospholipase A2 the enzyme that is activated by a G- protein-mediated mechanism in human platelets and is down-regulated by protein kinase C ? 74
Botulinum-A toxin injections into the detrusor muscle decrease nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity 74
Nerve Growth factor bladder tissue levels in patients with neurogenic detrusor overactivity before and after botulinum-A toxin injections into the detrusor muscle 73
Mitochondrial and nuclear secretory phospholipases A2: potential partecipation to life or death decision of neural cells. 73
The presence of a secretory phospholipase A2 in the nuclei of neuronal and glial cells of rat brain cortex 72
Secretory phospholipases A2 in neural cells: localization and functions 71
Trattamento dei disturbi vescicali sensitivi con tossina botulinica A: studio pilota 71
The effects of Calcium on reactive oxygen species elimination in brain mitochondria 71
Enzymic synthesis of ethanolamine plasmalogens through ethanolaminephospho-transferase activity in neurons and glial cells of rabbit in vitro 70
Protein kinase C inhibitors enhance G-protein induced phospholipase A2 activation in intact human platelets 69
Low molecular weight phospholipases A2 in mammalian brain and neural cells: roles in functions and dysfunctions. 68
The bladder urothelium: passive permeability and intravesical drug passive diffusion. 68
Determination of Nerve Growth Factor levels into human bladder wall by modified enzyme-linked immunoabsorbent assay. 67
Evidence that cytosolic phospholipase A2 is down-regulated by protein kinase C in intact human platelets stimulated with fluoroaluminate. 67
Platelet-activating factor: role in long-term potentiation and in brain damage 67
Involvment of group IIA phospholipase A2 (GIIA) in NGF-induced neuritogenesis of PC12 cells 65
Inhibition of PAF synthesis by stimulated human polymorphonuclear leucocytes with cloricromene, an inhibitor of phospholipase A2 activation 65
Role of Platelet-Activating Factor in long-term potentiation of the medial vestibular nuclei. 64
PAF levels in saliva are regulated by inflammatory cells 64
Group IIA secretory phospholipase A2 (GIIA) mediates apoptotic death during NMDA receptor activation in rat primary cortical neurons. 63
Respiratory state and release of mitochondrial phospholipase A2 63
The effect of calcium on reactive oxygen species elimination in brain mitochondria 63
Involvement of group IIA secretory phospholipase A2 (GIIA) in NGF-induced neuritogenesis of PC12 cells 63
Release of a phospholipase a2 from rat brain mithocondria. 62
Low Molecular Weight Phospholipases A2 in Mammalian Brain and Neural Cells: Roles in Functions and Dysfunctions 61
Membrane phosphatidylcholine pools and synthetic mechanisms. 61
Metabolism and functions of phosphatidylserine in mammalian brain. 61
Phospholipase A2 release from rat brain cortex mitochondria depends on respiratory state and precedes the liberation of cytochrome c 60
Livelli tissutali di Nerve growth factor nella ipertrofia prostatica benigna ed iperattività detrusoriale dopo terapia con tamsulosina. 60
Cloricromene inhibits leukotriene formation by human polymorphonuclear leukocytes by suppressing arachidonate release from membrane phospholipids. 58
Metabolic studies on ethanolamine phosphoglycerides in neuronal and glial cells. 57
Respiratory state and release of mitochondrial phospholipase A2. 56
Rat brain cortex mitochondria release group II secretory phospholipase A(2) under reduced membrane potential. 56
Role of protein kinase C in the release of arachidocic acid from platelets 56
Neural Lipids 55
Metabolism and functions of Platelet-Activating Factor in the nervous tissue. 54
Totale 8.496
Categoria #
all - tutte 37.172
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.172


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021559 0 0 0 0 0 79 93 8 143 49 109 78
2021/2022961 25 192 30 68 43 12 19 259 12 33 99 169
2022/20231.779 141 203 27 187 136 209 2 100 682 4 61 27
2023/2024669 34 69 31 6 10 9 174 24 91 7 135 79
2024/20251.440 47 178 102 51 193 42 30 105 258 71 228 135
2025/20261.674 242 198 148 442 443 201 0 0 0 0 0 0
Totale 8.866